Lemtrada approved in Canada for treatment of MS
Posted: Fri Dec 13, 2013 7:59 am
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis (RRMS), with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies........ Read More - http://www.ms-uk.org/lemtrada